{"id":11353,"date":"2022-07-01T20:34:20","date_gmt":"2022-07-02T00:34:20","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/advances-in-genomics-and-personalized-cancer-immunotherapy\/"},"modified":"2022-07-14T16:09:46","modified_gmt":"2022-07-14T20:09:46","slug":"personalized-medicine-cancer-immunotherapy","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/personalized-medicine-cancer-immunotherapy","title":{"rendered":"Advances in Genomics and Personalized Cancer Immunotherapy"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/05_91DuR2wY\" width=\"560\"><\/iframe><\/p>\n<p>Cancer treatment has historically taken a &quot;one size fits all&rdquo; approach. However, as scientists have learned more the role of genetic mutations in cancer, more personalized approaches have become possible.&nbsp;<\/p>\n<p>In this webinar for patients and caregivers, Robert D. Schreiber, PhD, of&nbsp;Washington University School of Medicine in St. Louis discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors as well as how these tools are being utilized to develop personalized immunotherapy strategies for patients with a variety of cancers<\/p>\n<p>Robert D. Schreiber, PhD, is the director of the Center for Human Immunology and Immunotherapy Programs, the co-leader of the Tumor Immunology Program of the Siteman Cancer Center, and the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology &amp; Immunology at the Washington University School of Medicine in St. Louis. Dr. Schreiber&rsquo;s career has spanned the entire spectrum from laboratory research&mdash;where he has made monumental contributions to our fundamental understanding of adaptive immunity and cancer immunology&mdash;all the way to the clinic, where he is now focused on improving the effectiveness of personalized, patient-specific vaccine approaches against cancer. These clinical efforts are currently being explored in several clinical trials currently underway as well as several more that are planned.<\/p>\n<p>The &quot;Cancer Immunotherapy and You&quot; webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis.&nbsp;<\/p>\n<p>Browse our <a href=\"https:\/\/www.youtube.com\/playlist?list=PLiGDIj2dVt-iOiV34MnZIkTiVF3iFgF_o\" target=\"_blank\" rel=\"noopener\">Cancer Immunotherapy and You Webinar Series playlist<\/a> on YouTube or visit the <a href=\"\/events\/webinars\">Webinars page<\/a> on our website to see other webinars in this series.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Robert D. Schreiber of Washington University School of Medicine in St. Louis discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.<\/p>\n","protected":false},"featured_media":5074,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11353","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Personalized Medicine and Cancer Immunotherapy<\/title>\n<meta name=\"description\" content=\"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Personalized Medicine and Cancer Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:09:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1460\" \/>\n\t<meta property=\"og:image:height\" content=\"949\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Personalized Medicine and Cancer Immunotherapy\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy\",\"name\":\"Personalized Medicine and Cancer Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg\",\"datePublished\":\"2022-07-02T00:34:20+00:00\",\"dateModified\":\"2022-07-14T20:09:46+00:00\",\"description\":\"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg\",\"width\":1460,\"height\":949},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Advances in Genomics and Personalized Cancer Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Personalized Medicine and Cancer Immunotherapy","description":"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy","og_locale":"es_ES","og_type":"article","og_title":"Personalized Medicine and Cancer Immunotherapy","og_description":"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.","og_url":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:09:46+00:00","og_image":[{"width":1460,"height":949,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_title":"Personalized Medicine and Cancer Immunotherapy","twitter_description":"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy","url":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy","name":"Personalized Medicine and Cancer Immunotherapy","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg","datePublished":"2022-07-02T00:34:20+00:00","dateModified":"2022-07-14T20:09:46+00:00","description":"Dr. Robert D. Schreiber (WUSTL) discusses how advances in our understanding of genomics have enabled doctors to identify the mutations driving individual tumors.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/db8a7dca-0911-488a-8825-8f8f5c3c09fa.jpg","width":1460,"height":949},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/personalized-medicine-cancer-immunotherapy#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Advances in Genomics and Personalized Cancer Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/5074"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11353"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11353"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11353"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11353"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11353"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11353"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}